Recent Developed Nitrogen/Sulfur Heterocyclic Compounds with Marked and Selective Antiviral Activities (Microreview)

Author:

Mutalabisin Fathiy1,Ghafarikhaligh Mahta2,Mihankhah Peyman3ORCID,Khaligh Nader Ghaffari1ORCID

Affiliation:

1. Nanotechnology and Catalysis Research Center, Institute for Advanced Studies, Universiti Malaya, Kuala Lumpur 50603, Malaysia

2. Department of Biomedicine, Faculty of Biology, Bielefeld University, Bielefeld D-33615, Germany

3. Mechanical, Automotive & Materials Engineering, Faculty of Engineering, University of Windsor, Windsor, Ontario (ON) N9B 3P4, Canada

Abstract

Abstract: Millions of deaths have been reported due to viral infections in medical history, and various viral infections are mentioned as the main cause of death. Although different types of research have been conducted to develop effective medication, there is a high demand to truly cure various viral infections. The resistance to the existence of antiviral drugs on the market is the main threat to human health, and an intrinsic demand to develop and synthesize new scaffolds is highly required to find less toxicity and high antiviral activity. Nitrogen-sulfur heterocyclic compounds have extensively exhibited efficient biological and pharmacological activity against viral species, and physicochemical and pharmacokinetic properties. In this microreview, recently developed nitrogen-sulfur heterocyclics and their performance with marked and selective antiviral activities are summarized. We hope this micro-review will help early scientists interested in the design of new compounds with selective and pronounced antiviral activities to identify and satisfy the necessary criteria for the further development of nitrogen-sulfur heterocyclic compounds.

Funder

Nippon Sheet Glass Foundation for Materials Science and Engineering, Japan

Ministry of High Education (MOHE), Malaysia

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry

Reference72 articles.

1. Serban G.; Synthetic compounds with 2-amino-1,3,4-thiadiazole moiety against viral infections. Molecules 2020,25(4),942

2. Rohwer F.; Barott K.; Viral information. Biol Philos 2013,28(2),283-297

3. Woster P.M.; Antiviral agents and protease inhibitors. In: In Foye’s Principles of Medicinal Chemistry; Lemke, T.L.; Williams, D.A.; Roche, V.F.; Zito, S.W. Lippincott Williams and Wilkins, Wolters Kluwer: Baltimore, MD, USA, 2013,pp. 1274-1302

4. Berzofsky J.A.; Ahlers J.D.; Janik J.; Morris J.; Oh S.K.; Terabe M.; Belyakov I.M.; Progress on new vaccine strategies against chronic viral infections. J Clin Invest 2004,114,450-462

5. World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017, Weekly epidemiological record. 2020. Available from: [Accessed on: Jan 11, 2020].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3